𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Should patients with rheumatoid arthritis receive statin therapy?

✍ Scribed by Paul M Ridker; Daniel H. Solomon


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
71 KB
Volume
60
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Functional and work outcomes improve in
✍ Macedo, Alyssa M. ;Oakley, Stephen P. ;Panayi, Gabriel S. ;Kirkham, Bruce W. πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 207 KB πŸ‘ 1 views

## Abstract ## Objective Work disability is a serious consequence of rheumatoid arthritis (RA). We conducted a 6‐month, prospective randomized controlled trial comparing assessments of function, work, coping, and disease activity in employed patients with RA receiving occupational therapy interven

Bronchiolitis in a rheumatoid arthritis
✍ J. Desmond O'Duffy; Harvinder S. Luthra; K. Krishnan Unni; Robert E. Hyatt πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 379 KB πŸ‘ 1 views

A patient with severe rheumatoid arthritis and sicca symptoms was treated with auranofin. During auranofin therapy, she developed irreversible airways obstruction due to bronchiolitis. Whereas this complication could have been due to her underlying disease, we discuss here the possibility of its bei

Acute febrile toxic reaction in patients
✍ Ricardo Blanco; Victor M. MartΓ­nez-Taboada; Miguel A. GonzΓ‘lez-Gay; Jose Armona; πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 489 KB πŸ‘ 2 views

## Objective: To assess the frequency and clinical features of an acute febrile toxic reaction (aftr) in patients with refractory rheumatoid arthritis (ra) receiving combined therapy with methotrexate (mtx) and azathioprine (aza). ## Methods: A cohort of 43 ra patients being treated with mtx/aza

Medical resource use and costs among rhe
✍ Griffiths, Robert I. ;Bar-Din, Miriam ;MacLean, Catherine H. ;Sullivan, Erin M. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 201 KB πŸ‘ 2 views

## Objective: To identify costs among rheumatoid arthritis (ra) patients receiving alternative disease-modifying antirheumatic drug (dmard) therapies. ## Methods: Using managed care organization data, we identified members who (a) were prescribed any dmard therapy for two consecutive months betwe